Avelumab With Axitinib in Persistent or Recurrent Cervical Cancer After Platinum-based Chemotherapy

NCT03826589 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

23

Enrollment

OTHER

Sponsor class

Conditions

Cervical Cancer

Interventions

DRUG: Avelumab
DRUG: Axitinib

Sponsor

The University of Hong Kong